LMT Consolidates After a 26% Rally, With Shorts Staying Thin

Lockheed Martin has spent the past week digesting a 26% one-month price surge, with short sellers making no meaningful push against the move and the analyst community still busy raising targets in its wake.

Short interest on LMT is not a story worth dwelling on, but it is worth noting: at 1.1% of the free float, there is effectively no organised bear position in the stock. That figure has crept up roughly 7% over the past month, from around 2.41 million shares to 2.57 million, but the absolute level remains negligible. The borrow market confirms the same picture. Availability is vast, with roughly 7,867% more shares available to lend than are currently borrowed, comfortably above the 52-week low of 4,529%. Cost to borrow has drifted back down to 0.43%, 15% cheaper than a week ago. Nothing in the lending market suggests any pressure building against the stock. Options positioning is equally muted, with the put/call ratio at 0.80, barely above its 20-day average of 0.79 and well off the 52-week defensive extreme of 1.04.

The more active story is on the analyst side, and it has moved in one clear direction since the Q3 earnings print on October 22. That print drove a 9.6% one-day move and a 16.7% gain over the following five days. What followed was a wave of target raises: Guggenheim initiated with a Buy and a $735 target on November 4, Wells Fargo lifted its target to $700 from $600 while keeping an Equal-Weight rating, and Morgan Stanley's upgrade to Overweight with an $835 target, issued October 26, remains the most bullish published view on the stock. JP Morgan, Citigroup, UBS, RBC, and Barclays all raised targets too, though most of those firms kept neutral or sector-perform ratings. The dispersion in targets is wide. Barclays sits at $560, Morgan Stanley at $835, with the consensus mean at $652. With the stock at $639, most of the neutral-rated analysts are pointing to targets only modestly above the current price, while the upgrade from Morgan Stanley implies significantly more room. The analyst recommendation score ranks in the 97th percentile across the ORTEX universe, an unusual alignment in directional target revision even where outright ratings have not moved.

The bull case centres on the record $292 billion backlog, the 10-year F-35 framework agreement securing at least 850 aircraft, and third-quarter revenue of $20.7 billion with free cash flow of $3 billion. The bear case is more structural: Aeronautics derives more than two-thirds of revenue from the F-35, and the loss of NGAD in March 2025 and the absence of any role in the F/A-XX program leave the segment's long-term growth dependent on a single platform. Free cash flow is expected to decline in 2027 on pension pressure and elevated capex, with 2028 estimates in the $5.7 to $6.0 billion range implying weaker cash conversion. The price-to-earnings multiple has expanded by roughly 3.7 points over the past 30 days to 19.4x, and price-to-book has moved to 11.1x, up 1.5 points over the same period.

One piece of colour from the alt data layer: retail attention spiked sharply around earnings, with a Wikipedia-based attention z-score of 2.39, well above normal levels as of October 28. None of the six datasets in LMT's alt data coverage carry a measured lead against the company's reported figures, so the attention spike is context rather than signal. The buybacks dataset records the smallest Q2 buyback spend on record since 2009, at zero, for the April 2026 quarter.

Among peers, the week's moves were mixed. LHX gained 7.0% and GD added 5.5%, both outpacing LMT's 2.6% week. RTX added 4.7%. NOC was the laggard, essentially flat at down 0.2%. LMT's one-month surge of 26% remains the standout in the group. The COO, Frank St John, sold 3,899 shares across three transactions on October 23, the same day as the post-earnings run continued, with no price or value data disclosed in the filing. No open-market purchases were recorded over the past 90 days, and net insider activity over that window was a small net sale of 9,883 shares.

The next earnings event is scheduled for January 26, 2027, 83 days away. Between now and then, the stock's direction will likely hinge less on fresh news and more on whether the gap between the neutral-rated majority of analysts, clustered near current prices, and the Morgan Stanley bull case at $835 begins to close through further target revisions or remains a live debate.